Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery

Anesthesiology

Volumn 126, Issue 1, 2017, Pages 85-93

  Hajjar, Ludhmila Abrahao ^a   Vincent, Jean Louis ^d   Barbosa Gomes Galas, Filomena Regina ^a   Rhodes, Andrew ^e   Landoni, Giovanni ^f,g   Osawa, Eduardo Atsushi ^a   Melo, Renato Rosa ^a   Sundin, Marcia Rodrigues ^a   Grande, Solimar Miranda ^a   Gaiotto, Fabio A ^b   Pomerantzeff, Pablo Maria ^b   Dallan, Luis Oliveira ^b   Franco, Rafael Alves ^a   Nakamura, Rosana Ely ^a   Lisboa, Luiz Augusto ^b   De Almeida, Juliano Pinheiro ^a   Gerent, Aline Muller ^a   Souza, Dayenne Hianae ^a   Gaiane, Maria Alice ^a   Fukushima, Julia Tizue ^a   Park, Clarice Lee ^a   Zambolim, Cristiane ^a   Rocha Ferreira, Graziela Santos ^a   Strabelli, Tânia Mara ^c   Fernandes, Felipe Lourenco ^a   Camara, Ligia ^a   Zeferino, Suely ^a   Santos, Valter Garcia ^a   Piccioni, Marilde Albuquerque ^a   Jatene, Fabio Biscegli ^b   Costa Auler, Jose Otavio ^a   Filho, Roberto Kalil ^a   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Division of Cardiovascular Surgery   (United States)

^c Division of Infectious Diseases   (United States)

^d ERASME HOSPITAL   (Belgium)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NORADRENALIN; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DELIRIUM; DOUBLE BLIND PROCEDURE; FEMALE; FORWARD HEART FAILURE; HEART INDEX; HEART INFARCTION; HEART RATE; HEART SURGERY; HUMAN; HYPONATREMIA; INTRAAORTIC BALLOON PUMP; ISCHEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ISCHEMIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SHOCK; SURGICAL INFECTION; VASOPLEGIA; VASOPRESSIN BLOOD LEVEL; BRAZIL; COMPARATIVE STUDY; COMPLICATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

BRAZIL; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SHOCK; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASOPLEGIA; VASOPRESSINS;

EID: 84995450911     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001434     Document Type: Article

References (26)

1. Fischer GW, Levin MA: Vasoplegia during cardiac surgery: Current concepts and management. Semin Thorac Cardiovasc Surg 2010; 22:140-4
2. Weis F, Kilger E, Beiras-Fernandez A, Nassau K, Reuter D, Goetz A, Lamm P, Reindl L, Briegel J: Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006; 61:938-42
3. Luckner G, Dünser MW, Jochberger S, Mayr VD, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder W, Mayr AJ, Friesenecker B: Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005; 33:2659-66
4. Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW: Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med 2012; 38:950-8
5. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-95
6. Barrett LK, Singer M, Clapp LH: Vasopressin: Mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007; 35:33-40
7. Dünser MW, Mayr AJ, Stallinger A, Ulmer H, Ritsch N, Knotzer H, Pajk W, Mutz NJ, Hasibeder WR: Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 2002; 28:746-51
8. Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hébert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ: The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010; 36:83-91
9. Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(9 Suppl):II-286-90
10. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-9
11. Elgebaly AS, Sabry M: Infusion of low-dose vasopressin improves left ventricular function during separation from cardiopulmonary bypass: A double-blind randomized study. Ann Card Anaesth 2012; 15:128-33
12. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
13. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-87
14. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88: S2-22
15. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
16. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-10
17. Torgersen C, Dünser MW, Wenzel V, Jochberger S, Mayr V, Schmittinger CA, Lorenz I, Schmid S, Westphal M, Grander W, Luckner G: Comparing two different arginine vasopressin doses in advanced vasodilatory shock: A randomized, controlled, open-label trial. Intensive Care Med 2010; 36:57-65
18. Fergusson D, Aaron SD, Guyatt G, Hébert P: Postrandomisation exclusions: The intention to treat principle and excluding patients from analysis. BMJ 2002; 325:652-4
19. Russell JA: Vasopressin in septic shock. Crit Care Med 2007; 35(9 Suppl):S609-15
20. Holmes CL, Walley KR: Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 2009; 15:398-402
21. Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E: Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg 2010; 5:17
22. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC: Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116:973-80
23. Gordon AC, Wang N, Walley KR, Ashby D, Russell JA: The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock. Chest 2012; 142:593-605
24. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group: A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-9
25. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-21
26. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989; 256(2 Pt 2):F274-8